Literature DB >> 28193767

The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer.

Richard L Bennett1, Alok Swaroop1, Catalina Troche1, Jonathan D Licht1.   

Abstract

The nuclear receptor-binding SET Domain (NSD) family of histone H3 lysine 36 methyltransferases is comprised of NSD1, NSD2 (MMSET/WHSC1), and NSD3 (WHSC1L1). These enzymes recognize and catalyze methylation of histone lysine marks to regulate chromatin integrity and gene expression. The growing number of reports demonstrating that alterations or translocations of these genes fundamentally affect cell growth and differentiation leading to developmental defects illustrates the importance of this family. In addition, overexpression, gain of function somatic mutations, and translocations of NSDs are associated with human cancer and can trigger cellular transformation in model systems. Here we review the functions of NSD family members and the accumulating evidence that these proteins play key roles in tumorigenesis. Because epigenetic therapy is an important emerging anticancer strategy, understanding the function of NSD family members may lead to the development of novel therapies.
Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28193767      PMCID: PMC5453381          DOI: 10.1101/cshperspect.a026708

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  123 in total

1.  NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15).

Authors:  Roberto Rosati; Roberta La Starza; Angelo Veronese; Ana Aventin; Christine Schwienbacher; Teresa Vallespi; Massimo Negrini; Massimo F Martelli; Cristina Mecucci
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

2.  Transition state for the NSD2-catalyzed methylation of histone H3 lysine 36.

Authors:  Myles B Poulin; Jessica L Schneck; Rosalie E Matico; Patrick J McDevitt; Michael J Huddleston; Wangfang Hou; Neil W Johnson; Sara H Thrall; Thomas D Meek; Vern L Schramm
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

3.  Distinctive signatures of histone methylation in transcribed coding and noncoding human beta-globin sequences.

Authors:  AeRi Kim; Christine M Kiefer; Ann Dean
Journal:  Mol Cell Biol       Date:  2006-12-11       Impact factor: 4.272

4.  Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma.

Authors:  María Berdasco; Santiago Ropero; Fernando Setien; Mario F Fraga; Pablo Lapunzina; Régine Losson; Miguel Alaminos; Nai-Kong Cheung; Nazneen Rahman; Manel Esteller
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

5.  NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.

Authors:  Gang G Wang; Ling Cai; Martina P Pasillas; Mark P Kamps
Journal:  Nat Cell Biol       Date:  2007-06-24       Impact factor: 28.824

6.  Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.

Authors:  Mark A Dawson; Rab K Prinjha; Antje Dittmann; George Giotopoulos; Marcus Bantscheff; Wai-In Chan; Samuel C Robson; Chun-wa Chung; Carsten Hopf; Mikhail M Savitski; Carola Huthmacher; Emma Gudgin; Dave Lugo; Soren Beinke; Trevor D Chapman; Emma J Roberts; Peter E Soden; Kurt R Auger; Olivier Mirguet; Konstanze Doehner; Ruud Delwel; Alan K Burnett; Phillip Jeffrey; Gerard Drewes; Kevin Lee; Brian J P Huntly; Tony Kouzarides
Journal:  Nature       Date:  2011-10-02       Impact factor: 49.962

7.  Cytological Features of a Variant NUT Midline Carcinoma of the Lung Harboring the NSD3-NUT Fusion Gene: A Case Report and Literature Review.

Authors:  Shiho Kuroda; Shioto Suzuki; Akira Kurita; Mari Muraki; Yoichiro Aoshima; Fumihiko Tanioka; Haruhiko Sugimura
Journal:  Case Rep Pathol       Date:  2015-01-19

8.  Structural basis for PHDVC5HCHNSD1-C2HRNizp1 interaction: implications for Sotos syndrome.

Authors:  Andrea Berardi; Giacomo Quilici; Dimitrios Spiliotopoulos; Maria Angeles Corral-Rodriguez; Fernando Martin-Garcia; Massimo Degano; Giovanni Tonon; Michela Ghitti; Giovanna Musco
Journal:  Nucleic Acids Res       Date:  2016-02-20       Impact factor: 16.971

9.  NSD1 analysis for Sotos syndrome: insights and perspectives from the clinical laboratory.

Authors:  Darrel J Waggoner; Gordana Raca; Katherine Welch; Melissa Dempsey; Ethan Anderes; Irina Ostrovnaya; Asem Alkhateeb; Junichi Kamimura; Naomichi Matsumoto; G Bradley Schaeffer; Christa Lese Martin; Soma Das
Journal:  Genet Med       Date:  2005-10       Impact factor: 8.822

10.  Identification of druggable cancer driver genes amplified across TCGA datasets.

Authors:  Ying Chen; Jeremy McGee; Xianming Chen; Thompson N Doman; Xueqian Gong; Youyan Zhang; Nicole Hamm; Xiwen Ma; Richard E Higgs; Shripad V Bhagwat; Sean Buchanan; Sheng-Bin Peng; Kirk A Staschke; Vipin Yadav; Yong Yue; Hosein Kouros-Mehr
Journal:  PLoS One       Date:  2014-05-29       Impact factor: 3.240

View more
  53 in total

1.  Whsc1 links pluripotency exit with mesendoderm specification.

Authors:  Tian V Tian; Bruno Di Stefano; Grégoire Stik; Maria Vila-Casadesús; José Luis Sardina; Enrique Vidal; Alessandro Dasti; Carolina Segura-Morales; Luisa De Andrés-Aguayo; Antonio Gómez; Johanna Goldmann; Rudolf Jaenisch; Thomas Graf
Journal:  Nat Cell Biol       Date:  2019-06-24       Impact factor: 28.824

Review 2.  Epigenetic regulatory mutations and epigenetic therapy for multiple myeloma.

Authors:  Daphné Dupéré-Richer; Jonathan D Licht
Journal:  Curr Opin Hematol       Date:  2017-07       Impact factor: 3.284

3.  High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2.

Authors:  Nathan P Coussens; Stephen C Kales; Mark J Henderson; Olivia W Lee; Kurumi Y Horiuchi; Yuren Wang; Qing Chen; Ekaterina Kuznetsova; Jianghong Wu; Sirisha Chakka; Dorian M Cheff; Ken Chih-Chien Cheng; Paul Shinn; Kyle R Brimacombe; Min Shen; Anton Simeonov; Madhu Lal-Nag; Haiching Ma; Ajit Jadhav; Matthew D Hall
Journal:  J Biol Chem       Date:  2018-06-26       Impact factor: 5.157

4.  Deletion of Mouse Setd4 Promotes the Recovery of Hematopoietic Failure.

Authors:  Xing Feng; Huimei Lu; Jingyin Yue; Megha Shettigar; Jingmei Liu; Lisa K Denzin; Zhiyuan Shen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-04-04       Impact factor: 7.038

Review 5.  Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease.

Authors:  Kamakoti P Bhat; H Ümit Kaniskan; Jian Jin; Or Gozani
Journal:  Nat Rev Drug Discov       Date:  2021-01-19       Impact factor: 84.694

6.  PTEN Methylation by NSD2 Controls Cellular Sensitivity to DNA Damage.

Authors:  Jinfang Zhang; Yu-Ru Lee; Fabin Dang; Wenjian Gan; Archita Venugopal Menon; Jesse M Katon; Chih-Hung Hsu; John M Asara; Priyanka Tibarewal; Nicholas R Leslie; Yang Shi; Pier Paolo Pandolfi; Wenyi Wei
Journal:  Cancer Discov       Date:  2019-06-19       Impact factor: 39.397

7.  Defining the NSD2 interactome: PARP1 PARylation reduces NSD2 histone methyltransferase activity and impedes chromatin binding.

Authors:  Xiaoxiao Huang; Richard D LeDuc; Luca Fornelli; Alissa J Schunter; Richard L Bennett; Neil L Kelleher; Jonathan D Licht
Journal:  J Biol Chem       Date:  2019-06-27       Impact factor: 5.157

Review 8.  Roles and regulation of histone methylation in animal development.

Authors:  Ashwini Jambhekar; Abhinav Dhall; Yang Shi
Journal:  Nat Rev Mol Cell Biol       Date:  2019-07-02       Impact factor: 94.444

9.  The catalytic domain of the histone methyltransferase NSD2/MMSET is required for the generation of B1 cells in mice.

Authors:  Marc-Werner Dobenecker; Jonas Marcello; Annette Becker; Eugene Rudensky; Natarajan V Bhanu; Thomas Carrol; Benjamin A Garcia; Rabinder Prinjha; Vyacheslav Yurchenko; Alexander Tarakhovsky
Journal:  FEBS Lett       Date:  2020-08-29       Impact factor: 4.124

Review 10.  Histone lysine methyltransferases in biology and disease.

Authors:  Dylan Husmann; Or Gozani
Journal:  Nat Struct Mol Biol       Date:  2019-10-03       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.